EVC insider files Form 144 to sell 39,238 common shares

Rhea-AI Filing Summary

EVC filed a Form 144 notice covering the proposed sale of common stock by an affiliated holder. The filing reports an intention to sell 39,238 shares of common stock through Merrill Lynch on the NYSE, with an aggregate market value of 103,281.22. The filing notes that 81,623,559 shares of common stock were outstanding.

The shares proposed for sale were acquired via restricted stock unit grants from the issuer, with 11,357 shares granted and vested on 12/31/2016 and 33,333 shares granted and vested on 12/31/2017. The approximate date of sale indicated is 11/21/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON STOCK	MERRILL LYNCH 333 S. HOPE ST. 39TH FLOOR LOS ANGELES CA 90071	39238	103281.22	81623559	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/31/2016	RSU GRANT	ISSUER			11357	12/31/2016	VEST
COMMON	12/31/2017	RSU GRANT	ISSUER			33333	12/31/2017	VEST

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does EVC's latest Form 144 filing disclose?

The Form 144 for EVC discloses a planned sale of 39,238 shares of common stock, with an aggregate market value of 103,281.22, to be sold through Merrill Lynch on the NYSE around 11/21/2025.

How many EVC shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 39,238 shares of EVC common stock, with the shares listed for sale through Merrill Lynch on the NYSE.

What is the reported market value of the EVC shares to be sold?

The Form 144 lists an aggregate market value of 103,281.22 for the 39,238 EVC common shares proposed to be sold.

How and when were the EVC shares in this Form 144 acquired?

The shares were acquired via RSU grants from the issuer, including 11,357 common shares granted and vested on 12/31/2016 and 33,333 common shares granted and vested on 12/31/2017.

What does the Form 144 say about EVC shares outstanding?

The filing reports that 81,623,559 shares of EVC common stock were outstanding, providing context for the proposed 39,238-share sale.

Does the EVC Form 144 include any representation about undisclosed information?

Yes. By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.